Pharmacologic Treatment of Hypertension in Adults Aged 60 Years or Older to Higher Versus Lower Blood Pressure Targets: A Clinical Practice Guideline From the American College of Physicians and the American Academy of Family Physicians.
Qaseem A, Wilt T, Rich R, Humphrey L, Frost J, Forciea M, Fitterman N, Barry M, Horwitch C, Iorio A, McLean R. Pharmacologic Treatment of Hypertension in Adults Aged 60 Years or Older to Higher Versus Lower Blood Pressure Targets: A Clinical Practice Guideline From the American College of Physicians and the American Academy of Family Physicians. Annals Of Internal Medicine 2017, 166: 430-437. PMID: 28135725, DOI: 10.7326/m16-1785.Peer-Reviewed Original ResearchConceptsSpecific blood pressure targetsBlood pressure targetsTarget systolic blood pressureSystolic blood pressureLower blood pressure targetsPressure targetsBlood pressureCardiac eventsPharmacologic treatmentTreatment goalsPatient populationAmerican CollegeFamily physiciansAmerican AcademyAdults Aged 60 YearsHigh cardiovascular riskTransient ischemic attackMajor cardiac eventsHistory of strokeClinical practice guidelinesTreatment of hypertensionTarget patient populationIschemic attackRecurrent strokeCause mortalityOral Pharmacologic Treatment of Type 2 Diabetes Mellitus: A Clinical Practice Guideline Update From the American College of Physicians.
Qaseem A, Barry M, Humphrey L, Forciea M, Fitterman N, Horwitch C, Kansagara D, McLean R, Wilt T. Oral Pharmacologic Treatment of Type 2 Diabetes Mellitus: A Clinical Practice Guideline Update From the American College of Physicians. Annals Of Internal Medicine 2017, 166: 279-290. PMID: 28055075, DOI: 10.7326/m16-1860.Peer-Reviewed Original ResearchConceptsType 2 diabetesOral pharmacologic treatmentGlycemic controlPharmacologic treatmentPatient populationAmerican CollegeSodium-glucose cotransporter 2 inhibitorsType 2Clinical Practice Guideline UpdateDipeptidyl peptidase-4 inhibitorsCotransporter 2 inhibitorsSGLT-2 inhibitorsSystolic blood pressurePeptidase-4 inhibitorsDPP-4 inhibitorsTarget patient populationTotality of evidenceACP guidelinesCerebrovascular morbidityCause mortalityOral medicationsOral therapyPharmacologic therapyBlood pressureHemoglobin A1c